![Moremeds_0](https://www.hivplusmag.com/media-library/moremeds-0.jpg?id=32676612&width=1200&height=800)
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
There are more than 10 dozen anti-HIV drugs in the developmental pipeline that pharmaceutical manufacturers and other research institutions are working on; that's roughly 50% more than were being worked on a year ago. The entry inhibitor category continues to show strong promise with 40 candidates'15 more than this time last year. Entry Inhibitors( Medication Name, Stage of Development, Developer) ' 15D, Preclinical, National Cancer Institute ' 15K, Preclinical, National Cancer Institute ' AK602, Phase I, Kumamoto University ' AMD3451 CCR5-CXCR4 blocker), Preclinical, Anormed ' Betulinic acid derivatives; Preclinical; University of North Carolina, Duke University, Vanderbilt University ' BMS-378806 (gp120 blocker), Phase I, Bristol-Myers Squibb ' CCR5mAb004 (CCR5 blocker), Preclinical, Human Genome Sciences ' D5 (artificial gp41 blocker), Preclinical, Merck ' DP-178 (fusion inhibitor), Preclinical, Weizmann Institute ' GBV-C (virus increases chemokines, including CCR5 blockers), Preclinical, University of Iowa ' gp41 inhibitor, Preclinical, New York Blood Center ' gp41 inhibitor, Preclinical, Locus Pharmaceuticals ' gp120-gp41 disulfide bond; Preclinical; Amsterdam Mathematical Center, Cornell University, University of Illinois at Chicago ' IC9564, Preclinical, Duke University ' Indolicidin, Preclinical,National Institutes of Health ' KD-247 (CCR5 blocker), Preclinical, Kumamoto University ' KRH-2731 (CXCR4 blocker), Preclinical, Kureha ''KRH-3140 (CXCR4 blocker), Preclinical, Kureha ' KRH-3955 (CXCR4 blocker), Preclinical, Kureha ''Maraviroc/UK-427 (CCR5 blocker), Phase III, Pfizer ''MDX-010, Preclinical, Medarex ' Monoclonal FAbs (gp41 blocker), Preclinical, National Institutes of Health ''NB-2 (gp41 blocker), Preclinical, Shibo and Kumar ' NB-64 (gp41 blocker), Preclinical, Shibo and Kumar ''NSC 13778 (gp120 blocker), Preclinical, SAIC-National Cancer Institute ' PRO-140 (monoclonal antibody), Phase I, Progenics ' Pyrrolidine (CCR5 blocker), Preclinical, Merck ' RANTES analogs (CCR5 blockers), Preclinical, University of Geneva ' RC-112, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Retrocyclin-1, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Sifuvirtide, Preclinical, Fusogen ' SP-01 A, Preclinical, Samaritan ' SP-10, Preclinical, Samaritan ' TAK-652 (CCR5 blocker), Preclinical, Takeda ' TNX-355 (monoclonal antibody), Phase II, Tanox and Biogen ' TR-999, Preclinical, Trimeris and Roche ' TR-1144, Preclinical, Trimeris and Roche ' UMIST, Preclinical, Genetic Innovation Network ' Vicriviroc/SCH-D (CCR5 blocker), Phase II, Schering Plough ' Zinc finger protein nucleases (CCR5 blockers), Preclinical, Sangamo Biosciences Integrase Inhibitors(Medication Name, Stage of Development, Developer) ' AVX-I, Preclinical, Avexa ' Beta-diketo acids, Preclinical, University of Parma and University of Sassari ' Carbazole derivative, Preclinical, Japan's National Institute of Infectious Diseases ' GSK-810871, Preclinical, GlaxoSmithKline ' Indolicidin, Preclinical, National Cancer Institute ' GS-9137 (JTK-303), Phase II, Gilead Sciences and Japan Tobacco ' ITI-367, Preclinical, George Washington University ' L-second generation, Preclinical, Merck ' MK-0518, Phase III, Merck ' Monophores, Preclinical, Sunesis ' Mycelium integrasone (fungal polyketide), Preclinical, Merck ' PL-2500, Preclinical, Procyon Biopharma ' Styrylquinoline derivatives, Preclinical, BioAlliance Pharma ' Theophyline, Preclinical, Thomas Jefferson University ' V-165, Preclinical, Rega Institute Maturation Inhibitors(Medication Name, Stage of Development, Developer) ' Alpha HGA, Phase I, Tripep ' Betulinic acid derivatives (entry, maturation inhibitors); Preclinical; University of North Carolina, Duke University, Vanderbilt University ' Chloroquine, Preclinical, Catholic University of Rome ' enJS56A1, Preclinical, University of Georgia ' PA-457 (capsid inhibitor), Phase II, Vitex ' RPI-MN, Preclinical, ReceptoPharm ' UK-201844, Preclinical, Pfizer Nonnucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' BILR 355 BS, Phase I/II, Boehringer-Ingelheim ' DOT (dioxolane thymidine), Phase I, University of Georgia ' GS9148, Preclinical, Gilead Sciences ' GSK-695634, Phase I, GlaxoSmithKline ' MIV-170, Preclinical, Medivir ' NVP C-8 substituent, Preclinical, Boehringer-Ingelheim ' Oligodeoxi-nucleotides, Preclinical, University of Zurich ' PBO-15c (pyrrolobenzoxazepinone), Preclinical, University of Siena ' Phenylthiazoylamines, Preclinical, Yale University ' Pyridinone derivatives, Preclinical, Rutgers University ' Quinolones, Preclinical, Wellcome Trust ' S-DABO derivatives, Preclinical, China's Fudan University ' SMP-610, Preclinical, Advanced Life Sciences ' SMP-717, Preclinical, Advanced Life Sciences ' Thiazol derivatives, Preclinical, Japan's Institute for Virus Research ' TMC-125 (etravirine), Phase III, Tibotec and Johnson & Johnson ' TMC-278 (diarylpyrimidine or DAPY), Phase II, Tibotec ' Tricyclic NNRTI, Preclinical, Bristol-Myers Squibb Nucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' 4-Ed4T, Preclinical, Kagoshima University ' AVX754, Phase I/II, Avexa ' BPH-218, Preclinical, University of Pittsburgh ' Branched 3 primers, Preclinical, University of Illinois ' Compound X, Preclinical, Tibotec ' D-FDOC, Preclinical, Emory University ' Dinucleoside polyphosphates, Preclinical, University of Miami ' DOT-TP, Preclinical, Emory University ' dTTP, Preclinical, University of Rochester ' E2-FdA, Preclinical, Kumamoto University ' Elvucitabine (ACH-126), Phase II, Achillion ' Herpesvirus saimiri, Preclinical, Temple University ' KMMP05, Preclinical, National Cancer Institute ' KP-1461, Phase I/II, Koronis ' Racivir, Phase I/II, Pharmasset ' Stampidine, Preclinical, Parker Hughes Institute ' Thiovir, Preclinical, Adventrx ' Triol, Preclinical, Cruz Foundation Protease Inhibitors(Medication Name, Stage of Development, Developer) ' A-681799, Preclinical, Abbott Laboratories ' Beta-lactams, Preclinical, University of Debrecen ' Brecanavir (GSK-640385), Phase II, GlaxoSmithKline ' GRL-02031, Preclinical, Kumamoto University ' PPL-100, Preclinical, Procyon Biopharma ' SPI-256, Preclinical, Sequoia ' UIC02031, Preclinical, Kumamoto University Others(Medication Name, Stage of Development, Developer) ' Alpha-v integrins, Preclinical, irsiCaixa Foundation and Merck ' BL-1050 (regulatory protein inhibitor), Preclinical, BioLine Rx ' CDK inhibitor, Preclinical, Gilead Sciences ' CNI-1493 (rev inhibitor), Preclinical, Heinrich Pette Institute ' Curcumin/diferuloylmethane (tat inhibitor), Preclinical, Jawaharlal Nehru Center ' Cycloamides, Phase I, University of Illinois ' Glycodendrimers (lipid raft carbohydrates), Preclinical, Penn State University ' HRG214 (caprine IgG), Preclinical, Virionyx ' IM (CDK9 inhibitor), Preclinical, Institute of Human Virology ' KU-55933 (ATM kinase inhibitor), Preclinical, Kudos Pharma ' MDI-P (electrolyzed free radical), Preclinical, Medical Discoveries ' Mifepristone (glucocorticoid antagonist), Phase I, University of Pittsburgh ' Oxadiazols (nuclear localization viral matrix blockers), Preclinical, International Therapeutics ' Poly acrylic acid, Preclinical, Chinese Academy of Science ' Resveretrol (Egr1 gene activator), Preclinical, National Cancer Institute ' Rev inhibitors, Preclinical, National Institutes of Health ' RPI (nicotinic acetylcholine receptor blocker), Preclinical, NutraPharma ' RSC-1838, Preclinical, GlaxoSmithKline and Shionogi ' RWJ67567 (p38 inhibitor), Preclinical, University of Pennsylvania and Johnson & Johnson ' siRNA constructs (rev/tat inhibitors), Preclinical, Beckman Institute ' siRNA molecule, Preclinical, CombiMatrix ' TRIM5-alpha (capsid inhibitor), Preclinical, Dana Farber Cancer Institute-NIAID
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM